Delivery Order SPE2DB20D3111-SPE2DB25FA6RA

Award Date 2/6/25
Potential Completion Date 2/28/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,605.44, is for the delivery of 4,567,850,322 units of the medication RYANODEX 250 MG VIALS. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.88, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $4,468.92 and a completion date of August 19, 2024. AmerisourceBergen, a for-profit organization, is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential medical commodities,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250MG VIAL 1S, a medical product, with a ceiling value of $4,816.32 and a performance period through February 27, 2025. The contract is a Firm Fixed Price, Indefinite Delivery type with no set-aside designation, indicating open competition....
This is a $3,210.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a period of performance through March 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,448.96, is for the supply of RYANODEX 250MG VIAL 1S, a medical product. The contract is a firm fixed-price delivery order with a performance period ending on May 14, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4567771250 RYANODEX 250 MG VIALS. The contract has a ceiling value of $3,210.88 and a period of performance through April 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ryanodex 250 mg vials, a medication used for the treatment of malignant hyperthermia. The contract is a firm fixed-price delivery order with a ceiling value of $1,605.44 and a performance period ending on May 19, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6RA
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,421.76, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has a period of performance through February 28, 2025 and is a Firm Fixed Price contract type.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 5:49 AM